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Abstract
Background: To examine age and sex specific incidence and 30 day case fatality for subarachnoid haemorrhage
(SAH) in Scotland over a 20 year period.
Methods: A retrospective cohort study using routine hospital discharge data linked to death records.
Results: Between 1986 and 2005, 12,056 individuals experienced an incident SAH. Of these 10,113 (84%) survived to
reach hospital. Overall age-standardised incidence rates were greater in women than men and remained relatively
stable over the study period. In 2005, incidence in women was 12.8 (95% CI 11.5 to 14.2) and in men 7.9 (95% CI 6.9 to
9.1). 30 day case fatality in individuals hospitalised with SAH declined substantially, falling from 30.0% in men and 33.9%
in women in 1986-1990 to 24.5% in men and 29.1% in women in 2001-2005. For both men and women, the largest
reductions were observed in those aged between 40 to 59 years. After adjustment for age, socio-economic status
and co-morbidity, the odds of death at 30 days in 2005 compared to odds of death in 1986 was 0.64 (0.54 to 0.76),
p < 0.001 for those below 70 years, and 1.14 (0.83 to 1.56), p = 0.4 in those 70 years and above.
Conclusions: Incidence rates for SAH remained stable between 1986 and 2005 suggesting that a better
understanding of SAH risk factors and their reduction is needed. 30 day case fatality rates have declined
substantially, particularly in middle-age. However, they remain high and it is important to ensure that this is not
due to under-diagnosis or under-treatment.
Background
Although subarachnoid haemorrhage (SAH) accounts
for only 5% of all strokes [1], its impact on the loss of
productive life years is similar to that of ischaemic
stroke [2]. Nearly one third of all stroke related years of
potential life lost before age 65 are attributable to SAH
[3]. Recognised risk factors for SAH include hyperten-
sion, alcohol excess and smoking [4].
An understanding of the epidemiology of SAH over
time enables strategic planning of treatment services,
ensures the appropriate targeting of preventive measures
and allows assessment of the effectiveness of existing
management strategies. Effective therapies include oral
nimodipine [5], neurosurgical clipping and endo-vascu-
lar coiling [6].
Existing studies have largely been confined to specific
age groups, do not present data separately for men and
women and have not reported detailed co-morbidity or
socioeconomic status. Furthermore, description of secu-
lar trends in incidence and case fatality are limited and
inconsistent [7-10].
The aim of the present study is to provide a compre-
hensive description of temporal trends in incidence and
30 day case fatality of SAH in Scotland using routinely
collected hospital discharge data and death record data
for the entire country over the period 1986 to 2005.
Methods
All emergency hospital care is provided by the National
Health Service in Scotland (NHSS). Details of all NHSS
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hospital discharges are recorded centrally and these are
linked at an individual patient level to subsequent death
anywhere in the United Kingdom. Discharge data
recorded include up to six diagnoses (one principal and
five secondary), coded according to the World Health
Organisation Classification of Diseases, age, sex, post-
code of residence, date of hospitalisation, length of stay
and specialty.
A first hospitalisation for subarachnoid haemorrhage
was defined as one with a principal diagnosis of subar-
achnoid haemorrhage (International Classification of
Diseases 9th Revision 430 and International Classifica-
tion of Diseases 10th Revision I60) and no previous hos-
pitalisation (principal or secondary position) for
cerebrovascular disease (ICD9 430-434, ICD10 I60 to
I69) within the previous five years. Traumatic subarach-
noid haemorrhage (ICD9 852; ICD10 S06.6) was
excluded. For the mortality analyses, a death was attrib-
uted to subarachnoid haemorrhage if the primary cause
of death on certification was subarachnoid haemorrhage
(ICD9 430 and ICD10 I60).
We pre-defined co-morbidities of interest which were:
diabetes, cancer, respiratory disease, heart failure, per-
ipheral arterial disease, atrial fibrillation, essential hyper-
tension, renal failure, coronary heart disease and alcohol
misuse. These co-morbidities were considered to be pre-
sent if recorded as either a secondary diagnosis during
the incident subarachnoid hospitalisation or as any diag-
nosis (primary or secondary) in the previous five years.
Specific interventional procedures amongst hospita-
lised patients were also identified using the relevant
OPCS4 codes: neurosurgical clipping (L33.2), endovas-
cular coiling (L35.1, L35.8) and CT angiography (L35.2).
This data was only available from 1989 onwards. Post-
code sectors of residence were used to assign socioeco-
nomic status to all individuals based upon the Carstairs
Morris index of deprivation [11].
Annual age and sex specific incidence rates of incident
events for total, non-hospitalised fatal and hospitalised
SAH were calculated using denominator data from the
1981, 1991 and 2001 censuses, with interpolation and
extrapolation for the intra-census years. Rates were stan-
dardised to the 2001 Scottish census population using
the direct standardisation method. Both hospitalised and
total 30 days case fatality were estimated, the latter
including non-hospitalised fatal incident events in the
numerator and denominator. Poisson regression analysis
was used to model the temporal trends in incidence of
all first SAH with adjustment for age and socio-eco-
nomic deprivation. Logistic regression analysis was used
to model the temporal trends in 30 days hospitalised
case fatality with adjustment for age, socio-economic
deprivation and comorbidity. Fractional polynomial ana-
lysis was used to determine the best fitting curvi-linear
relationship for the temporal trends of incidence and
case fatality with study year. We determined a priori to
conduct all analyses for men and women separately and
to test for age by study year interactions. All analyses
were carried out using STATA (Version 10, STATA
Corp.) and a significance level of 0.05 was used
throughout.
Results
Study populations
Hospitalised incident subarachnoid haemorrhage
Between 1st January 1986 and 31st December 2005,
10,113 patients were hospitalised in Scotland for inci-
dent SAH, 3,678 (36.4%) of which were men (see Table
1). Men had a mean age of 51.4 (SD 15.3) years and
women 56.0 (15.5) years [p value for difference <0.001].
Comparing the final 5 years of the study period (2001 to
2005) with the initial 5 years (1986 to 1990), the mean
age increased from 50.4 years (15.8) to 52.5 years (14.6)
in men [p = 0.003] and from 55.6 years (15.4) to 57.1
years (15.3) in women [p = 0.01]. For both men and
women, a socio-economic gradient was evident. Among
men, 17.0% of cases occurred in the least deprived
group compared with 21.2% in the most deprived group
[p < 0.001]; the respective proportions were 18.2% and
21.7% in women [p < 0.001]. The most commonly
coded co-morbid condition in men and women was
hypertension (8.1% in men and 4.9% in women), fol-
lowed by coronary heart disease (5.6% in men and 4.9%
in women). Intervention by endovascular coiling or neu-
rosurgical clipping was carried out in 34.9% of men and
44.8% of women hospitalised in 2005. During the period
1989 to 2005, of those patients receiving neurosurgical
clipping, 49.1% were aged under 50 years, and of those
receiving neurosurgical coiling, 46.0% were under 50.
The proportion of patients undergoing intervention is in
line with those observed in the literature [3,12,13].
Non-hospitalised fatal incident subarachnoid haemorrhage
Between 1st January 1986 and 31st December 2005, there
were 1,943 fatal incident SAH events in Scotland, in
which no hospitalisation occurred. 741 (38.1%) of cases
were men. The mean age of men (54.8 years [SD 15.1])
was less than that of women (60.4 years [15.1]; (95% CI
-5.3 to -4.0, p < 0.001). For both men and women, those
whose incident event was fatal were older than those
whose incident event led to hospital admission [p <
0.001]. Comparing the final 5 years of the study period
(2001 to 2005) with the initial 5 years (1986 to 1990),
the mean age increased from 52.7 years (SD 14.6) to
57.2 years (SD 15.1) in men [p = 0.004] and minimally
from 60.4 years (SD 14.8) to 60.8 years (SD 15.2) in
women [p = 0.9]. As for hospitalised incident SAH there
was a socioeconomic gradient; 18.4% of affected men
were in the least deprived category compared with
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22.9% in the most deprived category [p = 0.03]; the
respective proportions in women were 16.1% and 22.9%
[p < 0.001].
Age standardised population rates
Overall age standardised rates for incident SAH (per
100,000 population) were greater in women than in men
(Figure 1). In men and women rates were relatively
stable across the 20 year period [men, 9.7 (8.4 to 8.7) in
1986 and 7.9 (6.9 to 9.1) in 2005; women, 15.3 (13.8 to
16.8) in 1986 and 12.8 (11.5 to 14.2) in 2005]. After
adjustment, the relative risk of incident subarachnoid
haemorrhage in 2005 compared to 1986 was 0.99 (0.88
to 1.10), p = 0.8 in men and 0.95 (0.87 to 1.03), p = 0.2
in women.
30 day case fatality
Overall (hospitalised and non-hospitalised) 30 day case
fatality increased substantially with age in both men and
women, increasing from 28.5% in men and 24.6% in
women aged <40 years to 59.7% in men and 57.3% in
women in those aged 70 and over (Table 2). In hospita-
lised patients only, 30 day case fatality demonstrated a
similar relationship with age. In general, both overall
and hospitalised case fatality decreased over the course
of the study period. For both men and women the lar-
gest reductions in case fatality were observed for those
aged between 40-59 years. In hospitalised men aged 40
to 49 years, 30 day case fatality fell during the study per-
iod, from 30% in the period 1986-1990 to 21.4% in the
period 2001-2005 (32.6% and 18.8% in women respec-
tively). There were no improvements in case fatality for
patients aged 70 years and older.
In the adjusted analyses, there was a significant inter-
action between age and study year when modelling hos-
pitalised 30 day case fatality with a similar size of
interaction effect for men and women (interaction p
value for all patients = 0.001]. In those aged less than 70
years the odds ratio (OR) of odds of death at 30 days in
2005 compared to odds of death at 30 days in 1986 was
0.64 (0.54 to 0.76), p < 0.001. In those aged 70 years
and above the corresponding OR was 1.14 (0.83 to
1.56), p = 0.4.
Discussion
Overall Incidence of SAH in Men and Women
Subarachnoid haemorrhage accounts for nearly one
third of all stroke related years of potential life lost
before age 65 [3]. Between 1986 and 2005, 12,056 indivi-
duals in Scotland experienced an incident SAH. Of these
84% survived to reach hospital. Overall age standardised
incidence rates were greater in women [14.8 (13.4 to
16.3)] than in men [9.4 (8.1 to 10.6)] throughout the
study period, with an overall female to male ratio of
1.59. A recent systematic review reported an overall
incidence of 11.5 per 100,000 person-years in women
and 9.2 in men with an overall female to male ratio of
1.24 [14]. The reasons for the frequently reported higher
incidence of SAH in women compared to men is
unknown, although hormonal factors have been postu-
lated [15]. Although the evidence is conflicting, some
studies have suggested that hormone replacement ther-
apy is associated with a reduced risk of SAH [4,14].
Temporal Trends in Incidence of SAH
Age-adjusted incidence of SAH in both men and women
was relatively stable across the study period. Other stu-
dies [8,9,16] observed a similar pattern, although com-
parison is hindered by the use of different time periods.
Table 1 Descriptive statistics for men and women
hospitalised with an incident SAH between 1st January
1986 and 31st December 2005
Men Women
Overall 3,678 (36.4%) 6,435 (63.6%)
Age (years) - mean (SD) 51.4 (15.3) 56.0 (15.5)
Age (years) by study year - mean (SD)
1986 to 1990 50.4 (15.8) 55.6 (15.4)
1991 to 1995 50.3 (15.4) 54.5 (15.6)
1996 to 2000 52.1 (15.3) 56.8 (15.6)
2001 to 2005 52.5 (14.6) 57.1 (15.3)
Age groups (years)
< 40 823 (22.4%) 974 (15.1%)
40-49 830 (22.6%) 1247 (19.4%)
50-59 880 (23.9%) 1493 (23.2%)
60-69 675 (18.4%) 1363 (21.2%)
70+ 470 (12.8%) 1358 (21.1%)
Socio-economic deprivation
1-least deprived 603 (17.0%) 1134 (18.2%)
2 705 (19.9%) 1221 (19.6%)
3 714 (20.2%) 1205 (19.3%)
4 766 (21.6%) 1321 (21.2%)
5- most deprived 752 (21.2%) 1352 (21.7%)
Missing 138 (3.8%) 202 (3.1%)
Comorbid diagnoses
Alcohol misuse 165 (4.5%) 111 (1.7%)
Atrial fibrillation 80 (2.2%) 90 (1.4%)
Cancer 86 (2.3%) 167 (2.6%)
Coronary heart dis. 206 (5.6%) 316 (4.9%)
Diabetes 86 (2.3%) 105 (1.6%)
Hypertension 299 (8.1%) 583 (9.1%)
Heart failure 59 (1.6%) 84 (1.3%)
Peripheral arter. dis. 130 (3.5%) 195 (3.0%)
Renal failure 36 (1.0%) 57 (0.9%)
Respiratory disease 111 (3.0%) 247 (3.8%)
Any condition above 844 (22.9%) 1416 (22.0%)
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The absence of a decline in the incidence of SAH in Scot-
land, despite intensive efforts to reduce the prevalence of
risk factors [17] such as smoking, hypertension and alcohol
misuse is surprising and at odds with the declining trend
seen in the incidence of ischaemic stroke in Scotland [18].
It may reflect the younger age profile of SAH compared
with ischaemic stroke and a lack of impact of risk factor
reduction measures in younger individuals. It may also be
that the importance of genetic or other unrecognised risk
factors in SAH are higher than in ischaemic stroke, mean-
ing that any health education and behavioural change pro-
grammes will have less impact on this type of stroke.
Figure 1 Observed age standardised rates (per 100,000) for hospitalised, out of hospital deaths and total SAH in men and women.
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30 Day Case Fatality following Incident SAH
Early case fatality following SAH is high. In our study
16.1% of individuals (16.8% of men and 15.7% of
women) with incident SAH died out of hospital. This is
identical to the rate of out of hospital case-fatality
reported in a study that examined 800 incident cases in
which the diagnosis was verified by either CT or
necropsy in 99% [13], and consistent with a meta-analy-
sis which reported a probability of sudden death ranging
from 3% to 21% [19].
30 day case fatality was also high at 24.5% in men and
29.1% in women even in the period 2001 to 2005. These
figures are similar to those reported from other coun-
tries. In the Swedish Hospital Discharge and Cause of
Death Registry, 30.5% of men and 32.5% of women died
within 28 days between 1987 and 2002 [7]. Case fatality
increased steeply with age, rising from 27.0% in men
aged less than 40 years to 62.3% in those aged 70 and
over during the period 2001-2005. Again these findings
are consistent with Swedish studies which also observed
increasing case fatality with increasing age [7,20]. It has
been suggested that this may be due, in part, to less
aggressive management of SAH in the elderly [7]
although there is little evidence to support this.
Temporal Trends in 30 Day Case Fatality following
Incident SAH
The most important new finding of our study is the
substantial decline in 30 day case fatality rates in men
and women over the study period. These declines were
greatest in those aged 40 to 59 years. For the 40 to 49
year age group, case fatality fell from 30.0% in 1986-
1990 to 21.4% in 2001 to 2005 in men and from 32.6%
to 18.8% in women, and was not changed substantially
by adjustment for age, socio-economic deprivation and
co-morbidity. Overall case fatality, including out of hos-
pital deaths, also declined, although the relative magni-
tude of the decline was less than for hospitalised case
fatality. There are few recently published data with
which to compare these findings and none of the pub-
lished reports have examined age specific trends in case
fatality in men and women. The Swedish Hospital Dis-
charge and Cause of Death Registry Study reported an
absolute risk reduction in 28 day case fatality of 5.8% in
patients under 70 years and 3.5% in patients of 70 years
and older comparing the period 1995-2002 and 1987-
1994 [7]. A number of other studies have reported
stable case fatality rates for SAH. These include the
Dijon Stroke Study, the Perth Community Stroke Study
and a study carried out using the United States National
Hospital Discharge Survey [21]. However, the Dijon and
Perth Studies were based on small numbers [8,9]. The
National Hospital Discharge Survey Study examined in-
hospital mortality rates for SAH hospitalisations
between 1986 and 2001 [21]. During this time period
the number of hospitalisations increased along with the
mean age of those hospitalised. The analyses of in-hos-
pital case fatality were crude and did not take into
account the changing case mix over time. This may
have masked any improvement in outcome which varied
by age or sex. In an update of a previous meta-analysis,
including only population-based prospective studies,
Nieuwkamp et al. [10] examined changes in case fatality
in the period 1972 to 2003. 30 day case fatality did not
appear to have declined after the results were adjusted
for age and sex. However there was considerable hetero-
geneity in case finding and diagnostic approaches
among studies combined.
Changes in the investigation, medical and interven-
tional management of SAH, including the introduction
of CT angiography, use of nimodipine [22] and endovas-
cular coiling [6], may have contributed to the reduction
observed in 30 day case fatality. An audit [23] of the
management of and referral patterns for SAH patients
conducted in the South Thames area in 1997, showed
Table 2 Hospitalised and overall 30 days case fatality by
age, sex and study year
Hospitalised 30 days case fatality (%)
Age groups (years)
Study year < 40 40-49 50-59 60-69 70+ All ages
Men 1986 to 1990 21.8 30.0 27.4 33.3 46.2 30.0
1991 to 1995 15.5 22.4 23.7 32.3 46.7 25.7
1996 to 2000 17.3 21.3 26.3 39.2 52.1 29.3
2001 to 2005 17.7 21.4 17.6 27.5 49.6 24.5
All years 18.1 23.6 23.8 33.2 48.9 27.4
Women 1986 to 1990 18.1 32.6 31.0 38.2 46.0 33.9
1991 to 1995 17.7 26.2 26.1 32.2 40.9 28.5
1996 to 2000 13.6 22.3 25.8 30.4 48.2 29.7
2001 to 2005 17.4 18.8 24.4 32.6 47.1 29.1
All years 16.7 24.7 26.7 33.3 45.9 30.2
Overall 30 days case fatality (%)
Age groups (years)
Study year < 40 40-49 50-59 60-69 70+ All ages
Men 1986 to 1990 33.1 41.9 43.7 48.1 55.5 42.9
1991 to 1995 27.1 32.2 38.8 45.2 59.3 38.4
1996 to 2000 26.3 32.8 37.0 48.7 60.9 39.6
2001 to 2005 27.0 32.8 33.2 40.6 62.3 37.6
All years 28.5 34.6 38.0 45.6 59.7 39.6
Women 1986 to 1990 27.9 43.0 45.2 50.0 60.7 46.8
1991 to 1995 25.4 37.1 37.7 42.6 52.9 39.5
1996 to 2000 19.3 31.8 33.8 40.4 57.2 38.8
2001 to 2005 25.8 27.5 37.6 42.7 58.0 40.2
All years 24.6 34.7 38.4 44.0 57.3 41.2
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that for many patients care was deficient. In particular,
delays in obtaining CT scans, and the consequent delays
in diagnoses, prevented the early commencement of
treatment and appropriate referrals. Moves towards
defined patient pathways, increased understanding of
the need for rapid action and improved adherence to
guidelines may also have resulted in reductions in case
fatality over recent years.
Strengths and weaknesses of the study
This study has a number of strengths. As a result of
individual patient record linkage we were able to iden-
tify incident cases of both fatal out of hospital and hos-
pitalised SAH in an entire population over nearly 3
decades. There are some limitations to our study. We
used routinely collected and coded hospital discharge
data. These are audited by ISD on a four yearly cycle
and SAH is coded in a principal diagnostic position at
discharge with a high degree of accuracy, 95% [24]. Our
definition of a first SAH used a time dependant look
back period. It is possible that a very small number of
individuals may have been hospitalised previously for
SAH outside this period. Our study may have excluded
a small number of individuals with mild symptoms who
were not hospitalised.
Conclusions
30 day case SAH fatality rates have declined substan-
tially, especially in middle age patients. It is important
to ensure that the observed higher risk in the elderly is
not due to under-diagnosis or under-treatment.
Despite improvements in cardiovascular risk factors at
a population level, the incidence of SAH has not
declined. Subarachnoid haemorrhage remains an impor-
tant public health issue, especially in women.
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